Sponsor Pipeline

Caliway Biopharmaceuticals Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
3
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07733947 A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
3
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07140939 A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing… Subcutaneous Fat Not Yet Recruiting
NCT07526974 A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing… Subcutaneous Fat Not Yet Recruiting
NCT07733947 A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection… Subcutaneous Fat Not Yet Recruiting
Phase 2
NCT07608770 A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for… Subcutaneous Fat Recruiting
NCT06303570 A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in… Dercum's Disease Active, Not Recruiting
NCT07608757 A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for… Subcutaneous Fat Not Yet Recruiting
Get alerts when Caliway Biopharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free